We are live on ! Find out more
VRNA

Verona Pharma

Delisted

VRNA was delisted on the 6th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$39.9M
NMC
2
NEA Management Company
Maryland
$35.8M
RCM
3
RA Capital Management
Massachusetts
$31.8M
VC
4
Vivo Capital
California
$21.3M
PA
5
Perceptive Advisors
New York
$20.2M
NHAS
6
Novo Holdings A/S
Denmark
$18.3M +$5.46M +808,008 +45%
A
7
Abingworth
United Kingdom
$16.9M
PCH
8
Polar Capital Holdings
United Kingdom
$11.4M +$11M +1,625,000 New
ACM
9
Aisling Capital Management
New York
$9.33M
Wellington Management Group
10
Wellington Management Group
Massachusetts
$8.72M +$8.41M +1,245,699 New
SFM
11
Sphera Funds Management
Israel
$7.24M +$227K +33,603 +3%
GTC
12
Ghost Tree Capital
New York
$5.67M +$30K +4,444 +0.6%
TCM
13
Tekla Capital Management
Massachusetts
$5.26M +$1.87M +276,503 +58%
VP
14
venBio Partners
California
$1.39M
CH
15
CVI Holdings
Delaware
$1.25M -$1.8M -266,172 -60%
DCM
16
DAFNA Capital Management
California
$1.13M
FFM
17
Fairmount Funds Management
Pennsylvania
$700K
DADC
18
D.A. Davidson & Co
Montana
$693K +$78.1K +11,566 +13%
SSA
19
Schonfeld Strategic Advisors
New York
$334K -$45.9K -6,800 -12%
HS
20
HighVista Strategies
Massachusetts
$187K +$180K +26,681 New
Renaissance Technologies
21
Renaissance Technologies
New York
$174K +$168K +24,800 New
IWM
22
IHT Wealth Management
Illinois
$130K -$21.6K -3,200 -15%
HSBC Holdings
23
HSBC Holdings
United Kingdom
$105K +$102K +15,041 New
WS
24
Wedbush Securities
California
$84K -$211K -31,300 -72%
RG
25
Rathbones Group
United Kingdom
$84K +$80.8K +11,959 New